EUVIMED · CrossrefJournal
The Prostate
ISSN 0270-4137 · Wiley
Latest articles
Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)
Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial
Adult Levels of Testosterone Induce Prostatic Epithelial Hyperplasia During Mouse Prostate Development Through Puberty
Defining a Safe Biopsy Deferral Strategy in Patients With Low‐Risk or Equivocal MRI Findings Using Prostate‐Specific Antigen‐Based Metrics
GenProb‐PCSM: A Simplified Weighted Germline Score for Prostate Cancer‐Specific Mortality
Insulin‐Like Growth Factor Axis and Survival in Metastatic Hormone‐Sensitive Prostate Cancer: Post‐Hoc Analysis From the ENZAMET Phase 3 Trial
Hot‐Flash Treatment During Androgen Deprivation Therapy Needs a Sleep‐and‐Mood Safety Check
Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer
Prognostic Value of MRI‐Derived Apparent Diffusion Coefficient in Intermediate‐Risk Prostate Cancer Treated With Definitive Radiotherapy
Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes
Comparison of Gene Enrichment Between Prostate Tissue and Urine for Non‐Invasive Biomarker Development
Histological Prostatic Inflammation Is Associated With Storage Lower Urinary Tract Symptoms and Inflammatory/Fibrotic Marker Expression in Benign Prostate Biopsies
[ 177 Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME)
Androgen Receptor‐Immune Crosstalk in Metastatic Castration‐Resistant Prostate Cancer: From Context‐Dependent Remodeling to Biomarker‐Guided Translation
Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer
Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance
Issue Information
The 32nd Annual Prostate Cancer Foundation Scientific Retreat Report
Burden of Prostate Cancer in the United States of America (USA): 1990–2023, Global Burden of Disease (GBD) Study 2023
Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers
Prostatic Enlargement in Acromegaly Despite Preserved Lower Urinary Tract Function: A Cross‐Sectional Comparative Study
Plasma Steroid Trajectories From Day‐of‐Surgery Baseline After Robot‐Assisted Radical Prostatectomy for Prostate Cancer
Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI‐RADS 3 Lesions: A Two‐Center Retrospective Study
Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone‐Sensitive Prostate Cancer
Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort
Restoration of Mitochondrial Function: A Metabolic Perspective on “Directed Evolution” in Castration‐Resistant Prostate Cancer
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy: Comment
Comments on the Study “Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients”
Testicular Cancer Survivorship and Prostate Cancer—New Questions on Risk and Outcomes
Volumes
2026 · 2232025 · 1982024 · 1752023 · 1882022 · 1872021 · 1682020 · 1552019 · 2062018 · 1602017 · 1752016 · 1612015 · 1922014 · 1662013 · 1862012 · 1912011 · 1852010 · 1822009 · 1852008 · 1862007 · 1852006 · 1792005 · 1762004 · 1822003 · 1462002 · 1452001 · 1922000 · 2551999 · 2371998 · 2411997 · 2571996 · 2471995 · 1071994 · 1181993 · 741992 · 1041991 · 701990 · 861989 · 881988 · 751987 · 80
EUVIMED